Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01206348 · ClinicalTrials.gov registry record · Phase 4
Combination Treatment for Moderate to Severe Acne
A Phase 4 study, sponsored by Medicis Global Service Corporation.
- Completed
- Registry status
- Phase 4
- Development phase
- 97
- Enrollment target
NCT01206348 is a Phase 4 study that has completed, run by Medicis Global Service Corporation. The registered enrollment target is 97 participants.
The verdict
NCT01206348, a Phase 4 study, has completed, sponsored by Medicis Global Service Corporation.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 97 participants
- Enrollment target
Study Summary
To determine if a combination of three currently approved acne products are safe and effective for the treatment of moderate to severe acne
Interventions
- DRUG Minocycline, Clindamycin, Tretinoin, Benzoyl Peroxide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 97 participants |
| Start Date | 2010-09 |
| Est. Completion | 2011-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01206348
The ClinicalTrials.gov registry entry for NCT01206348 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 97 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medicis Global Service Corporation, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Minocycline, Clindamycin, Tretinoin, Benzoyl Peroxide is the first listed.
NCT01206348 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01206348 about?
NCT01206348 is a clinical study titled "Combination Treatment for Moderate to Severe Acne". To determine if a combination of three currently approved acne products are safe and effective for the treatment of moderate to severe acne
What is the current status of trial NCT01206348?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 97 participants. The study started on 2010-09. Estimated completion is 2011-07.
What interventions are being tested in trial NCT01206348?
The interventions under investigation include: Minocycline, Clindamycin, Tretinoin, Benzoyl Peroxide (DRUG).
Who is sponsoring clinical trial NCT01206348?
This trial is sponsored by Medicis Global Service Corporation, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.